Diabetes, Endocrine and Metabolic Disease
糖尿病、内分泌及代谢疾病
基本信息
- 批准号:9336606
- 负责人:
- 金额:$ 8.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1978
- 资助国家:美国
- 起止时间:1978-09-15 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): This is a competitive renewal for our longstanding Training Program in Diabetes, Endocrinology, and Metabolic Diseases. During the most recent funding cycle, 4 postdoctoral fellows were supported each year, with an additional postdoctoral fellow supported through a Minority Supplement. A total of 13 trainees working with 10 different mentors were supported during this cycle. The program is designed to accommodate PhD scientists, as well as physician scientists with MD or MD/PhD degrees, of whom most enter through the Penn Clinical Fellowship Program in Endocrinology, Diabetes, and Metabolism. Of the postdoctoral trainees supported by this T32 during the last 4 years who are no longer in training, three have junior faculty positions at Penn (two with current competing offers from outside academic institutions), one is a Senior Scientist at Cellular Dynamics International, and one is an Associate Director of Clinical Research at Teva Pharmaceuticals. For the next period, we request continued funding of four postdoctoral fellows. We also request continued support of Penn's NIDDK Medical Student Research Program, which has supported 22 medical students during this funding cycle. Our 19 training faculty have primary appointments in nine Medical School Departments and one Department in the School of Veterinary Medicine and consist of 12 professors, 5 associate professors, and 2 assistant professors. Seven members of the training faculty are women and one is an underrepresented minority. In the last funding cycle, five mentors left Penn or changed status to emeritus, seven were removed, and seven were appointed to the training grant. Training grant faculty direct programs in β-cell development and function, obesity, hormone action, physiology, diabetic complications, and genetics in humans and model organisms, with expertise in laboratory-based, translational, patient-oriented, and community-based research. This training program continues to provide superb preparation for scientists committed to careers in research into diabetes, endocrinology, and metabolism.
描述(由申请人提供):这是我们在糖尿病,内分泌学和代谢疾病的长期培训计划的竞争性更新。在最近的资助周期中,每年支持4名博士后研究员,并通过少数族裔补助金支持另外一名博士后研究员。在这一周期内,共有13名受训人员与10名不同的导师一起工作,得到了支助。该计划旨在容纳博士科学家,以及医学博士或医学博士/博士学位的医生科学家,其中大多数人通过宾夕法尼亚大学内分泌学,糖尿病和代谢临床奖学金计划进入。在过去4年中,由T32支持的不再接受培训的博士后学员中,有三人在宾夕法尼亚大学担任初级教师职位(其中两人目前与外部学术机构竞争),一人是细胞动力学国际的高级科学家,一人是Teva Pharmaceuticals的临床研究副主任。在下一阶段,我们要求继续资助四名博士后研究员。我们还要求继续支持宾夕法尼亚大学的NIDDK医学生研究计划,该计划在本资助周期内支持了22名医学生。我们的19个培训教师在9个医学院部门和兽医学院的一个部门有主要任命,包括12名教授,5名副教授和2名助理教授。培训教员中有7名妇女,1名是代表性不足的少数民族。在上一个资助周期中,五位导师离开了宾夕法尼亚大学或将身份改为名誉退休,七位被撤职,七位被任命为培训补助金。培训补助金教师直接计划在β细胞发育和功能,肥胖,激素作用,生理学,糖尿病并发症和遗传学在人类和模式生物,在实验室为基础的,翻译,面向患者,和社区为基础的研究的专业知识。该培训计划继续为致力于糖尿病,内分泌学和代谢研究的科学家提供极好的准备。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANNE R CAPPOLA其他文献
ANNE R CAPPOLA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANNE R CAPPOLA', 18)}}的其他基金
Developing Oral LT3 Therapy for Heart Failure
开发治疗心力衰竭的口服 LT3 疗法
- 批准号:
10026340 - 财政年份:2019
- 资助金额:
$ 8.18万 - 项目类别:
Developing Oral LT3 Therapy for Heart Failure
开发治疗心力衰竭的口服 LT3 疗法
- 批准号:
10164851 - 财政年份:2019
- 资助金额:
$ 8.18万 - 项目类别:
Developing Oral LT3 Therapy for Heart Failure
开发治疗心力衰竭的口服 LT3 疗法
- 批准号:
10400936 - 财政年份:2019
- 资助金额:
$ 8.18万 - 项目类别:
Midcareer Investigator Award in Patient-Oriented Research in Aging
以患者为导向的老龄化研究中职业生涯调查员奖
- 批准号:
8510209 - 财政年份:2013
- 资助金额:
$ 8.18万 - 项目类别:
Midcareer Investigator Award in Patient-Oriented Research in Aging
以患者为导向的老龄化研究中职业生涯调查员奖
- 批准号:
10444914 - 财政年份:2013
- 资助金额:
$ 8.18万 - 项目类别:
Midcareer Investigator Award in Patient-Oriented Research in Aging
以患者为导向的老龄化研究中职业生涯调查员奖
- 批准号:
10055441 - 财政年份:2013
- 资助金额:
$ 8.18万 - 项目类别:
Midcareer Investigator Award in Patient-Oriented Research in Aging
以患者为导向的老龄化研究中职业生涯调查员奖
- 批准号:
10615121 - 财政年份:2013
- 资助金额:
$ 8.18万 - 项目类别:
Midcareer Investigator Award in Patient-Oriented Research in Aging
以患者为导向的老龄化研究中职业生涯调查员奖
- 批准号:
8699642 - 财政年份:2013
- 资助金额:
$ 8.18万 - 项目类别:
Ghrelin and Strength Training in Frail Elderly
生长素释放肽与体弱老年人的力量训练
- 批准号:
8332309 - 财政年份:2011
- 资助金额:
$ 8.18万 - 项目类别:














{{item.name}}会员




